9 Meters Biopharma, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 11.35 million compared to USD 5.43 million a year ago. Basic loss per share from continuing operations was USD 0.8 compared to USD 0.6 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
2023 | Bidding Procedure Approved for 9 Meters Biopharma, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 14 | |
+94.72% | 1.25B | |
+2.57% | 986M | |
+30.83% | 869M | |
+2.11% | 667M | |
-0.36% | 653M | |
-.--% | 600M | |
+10.28% | 536M | |
-.--% | 500M | |
-10.52% | 470M |
- Stock Market
- Equities
- NMTRQ Stock
- News 9 Meters Biopharma, Inc.
- 9 Meters Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022